GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eagle Pharmaceuticals Inc (FRA:1E6) » Definitions » Shiller PE Ratio

Eagle Pharmaceuticals (FRA:1E6) Shiller PE Ratio : 2.33 (As of Jun. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Eagle Pharmaceuticals Shiller PE Ratio?

As of today (2024-06-05), Eagle Pharmaceuticals's current share price is €3.42. Eagle Pharmaceuticals's E10 for the quarter that ended in Jun. 2023 was €1.47. Eagle Pharmaceuticals's Shiller PE Ratio for today is 2.33.

The historical rank and industry rank for Eagle Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:

FRA:1E6' s Shiller PE Ratio Range Over the Past 10 Years
Min: 2.18   Med: 11.7   Max: 29.15
Current: 2.39

During the past years, Eagle Pharmaceuticals's highest Shiller PE Ratio was 29.15. The lowest was 2.18. And the median was 11.70.

FRA:1E6's Shiller PE Ratio is ranked better than
97.76% of 536 companies
in the Drug Manufacturers industry
Industry Median: 23.89 vs FRA:1E6: 2.39

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eagle Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2023 was €0.360. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €1.47 for the trailing ten years ended in Jun. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eagle Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for Eagle Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eagle Pharmaceuticals Shiller PE Ratio Chart

Eagle Pharmaceuticals Annual Data
Trend Sep13 Sep14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 21.00

Eagle Pharmaceuticals Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 20.49 21.00 18.56 12.24

Competitive Comparison of Eagle Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Eagle Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eagle Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eagle Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eagle Pharmaceuticals's Shiller PE Ratio falls into.



Eagle Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eagle Pharmaceuticals's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=3.42/1.47
=2.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eagle Pharmaceuticals's E10 for the quarter that ended in Jun. 2023 is calculated as:

For example, Eagle Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=0.36/128.7287*128.7287
=0.360

Current CPI (Jun. 2023) = 128.7287.

Eagle Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201309 -0.046 98.790 -0.060
201312 -0.230 98.326 -0.301
201403 -0.260 99.695 -0.336
201406 -0.155 100.560 -0.198
201409 -0.504 100.428 -0.646
201412 -0.316 99.070 -0.411
201503 1.210 99.621 1.564
201506 -0.472 100.684 -0.603
201509 -0.579 100.392 -0.742
201512 0.064 99.792 0.083
201603 -0.054 100.470 -0.069
201606 0.712 101.688 0.901
201609 0.650 101.861 0.821
201612 3.337 101.863 4.217
201703 1.328 102.862 1.662
201706 0.249 103.349 0.310
201709 0.822 104.136 1.016
201712 0.490 104.011 0.606
201803 0.138 105.290 0.169
201806 0.146 106.317 0.177
201809 0.780 106.507 0.943
201812 0.756 105.998 0.918
201903 0.549 107.251 0.659
201906 0.425 108.070 0.506
201909 -0.154 108.329 -0.183
201912 0.063 108.420 0.075
202003 -0.190 108.902 -0.225
202006 -0.018 108.767 -0.021
202009 0.433 109.815 0.508
202012 0.485 109.897 0.568
202103 -0.025 111.754 -0.029
202106 0.224 114.631 0.252
202109 -0.366 115.734 -0.407
202112 -0.425 117.630 -0.465
202203 3.096 121.301 3.286
202206 -0.700 125.017 -0.721
202209 -0.545 125.227 -0.560
202212 0.585 125.222 0.601
202303 0.411 127.348 0.415
202306 0.360 128.729 0.360

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eagle Pharmaceuticals  (FRA:1E6) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Eagle Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Eagle Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eagle Pharmaceuticals (FRA:1E6) Business Description

Traded in Other Exchanges
Address
50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ, USA, 07677
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

Eagle Pharmaceuticals (FRA:1E6) Headlines

No Headlines